Brand Name
Zemdri
Generic Name
Plazomicin
View Brand Information FDA approval date: June 29, 2018
Form: Injection
What is Zemdri (Plazomicin)?
ZEMDRI is an aminoglycoside antibacterial indicated for the treatment of patients 18 years of age or older with Complicated Urinary Tract Infections including Pyelonephritis.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment